🔴 Indaptus Therapeutics is trading 10.16% down today as biotech sector declines

Indaptus Therapeutics is trading 10.16% down at $3.27 as biotech sentiment deteriorates, with XBI declining 2.11% during regular trading.

• The decline follows a five-session rally from $1.22 on September 4 to $3.64 on September 15, suggesting consolidation after an unusually sharp advance.
• No new company-specific negative announcement was identified; the recent $24 million financing was announced September 14.
• Trading activity is currently below average, with reported volume of 337.69K versus 2.33 million average volume, supporting sector weakness rather than a fresh company catalyst.